Working… Menu
Trial record 1 of 1 for:    Xbrane
Previous Study | Return to List | Next Study

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD (XPLORE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03805100
Recruitment Status : Active, not recruiting
First Posted : January 15, 2019
Last Update Posted : July 30, 2021
Stada Arzneimittel AG
Information provided by (Responsible Party):
Xbrane Biopharma AB

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 11, 2021
Estimated Study Completion Date : December 2021